MKI67 and laryngeal carcinoma: EGFR and P53 showed consistent evidence for not being predictive of local control after primary radiotherapy, whereas the proliferation marker Ki-67 is of interest for predicting local control in laryngeal cancer patients treated with radiotherapy.